Press Release: September 30, 2003

HP Supports "Individualized Medicine" Initiative at Partners HealthCare

Collaborative life science initiative to accelerate genomics in research and clinical medicine
PALO ALTO, Calif., and BOSTON, Sept. 30, 2003

HP (NYSE:HPQ) and Partners HealthCare today announced a multi-year, multi-million dollar sponsorship agreement in which HP will provide solutions, services and research collaboration to support Partners' efforts to accelerate clinical genomics and advance the concept of "individualized medicine."

The sophisticated combination of clinical research, genetic and genomic data, and information technologies - together known as physiological genomics - is expected to revolutionize medical treatment and lead to personalized, or individualized, medicine.

HP will facilitate Partners' efforts to develop a genetic computing platform supporting research and clinical activities at the Harvard Medical School - Partners HealthCare Center for Genetics and Genomics (HPCGG).

"We believe HP's strength in information technology and Partners' expertise in healthcare can help realize our shared vision of accelerating individualized medicine," said Dick Lampman, senior vice president of research and director, HP Labs. "HP is also excited about working with Partners to develop new wireless, mobile technologies for use in clinics and medical research."

HP was selected to support the physiological genomics initiative by delivering the following solutions and services: high-end technical computing servers, industry-standard HP ProLiant servers, HP StorageWorks systems, HP Openview IT service management software, and consulting and support services from HP Services. HP Labs will lead the research collaboration.

"To turn the vision of individualized medicine to reality requires the convergence of IT, research and healthcare," said John Glaser, chief information officer, Partners HealthCare. "HPCGG is in a unique position to combine the use of technology and research to revolutionize the delivery of healthcare to benefit patients."

"The development of physiological genomics will lead to a better understanding of health and disease, helping us find the right therapeutic targets and determining which drugs are most appropriate for individual patients. HP's involvement is an important step toward that goal," said Raju Kucherlapati, scientific director, HPCGG.

HPCGG provides Harvard Medical School and Partners with state-of-the-art facilities, technology, training, tools and resources required to promote genetics and genomics in research and clinical medicine.

With the foundation of HP's solution and services for Partners' genetic computing platform, the HPCGG can strive to achieve its mission to:

  • Build an infrastructure of core facilities and services to integrate and leverage HPCGG assets in providing and supporting genetic and genomic activities;

  • Establish an academic unit for intellectual collaboration and activity;

  • Support the Laboratory for Molecular Medicine to deliver molecular diagnostics testing and genetic counseling services; and

  • Expand the medical genetics program to deliver clinical services, research and education programs for patients and clinicians and faculty.

HP and HPCGG will leverage existing and new alliances, partners and suppliers to contribute to the mission of the HPCGG. By creating a network of complementary industrial partners with core technologies in pharmaceuticals, imaging, medical devices and biotechnology, HPCGG will have additional resources and expertise to further its mission.

About Partners HealthCare (

Partners HealthCare is a nonprofit integrated health care system founded in 1994 by Brigham and Women's Hospital and Massachusetts General Hospital. Partners is a teaching affiliate of Harvard Medical School. Partners' mission is to provide the highest quality patient care, find new treatments and cures through medical research, and train the clinicians of tomorrow.

About HP

HP is a technology solutions provider to consumers, businesses and institutions globally. The company's offerings span IT infrastructure, personal computing and access devices, global services and imaging and printing for consumers, enterprises and small and medium businesses. For the last four quarters, HP revenue totaled $71.3 billion. More information about HP is available at

This news release contains forward-looking statements that involve risks, uncertainties and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties and assumptions include the possibility that the market for the sale of certain products and services may not develop as expected; that development and performance of these products and services may not proceed as planned; and other risks that are described from time to time in HP's Quarterly Report on Form 10-Q for the period ended July 31, 2003 and HP's other Securities and Exchange Commission reports filed after HP's Annual Report on Form 10-K for the fiscal year ended October 31, 2002. If any of these risks or uncertainties materializes or any of these assumptions proves incorrect, HP's results could differ materially from HP's expectations in these statements. HP assumes no obligation and does not intend to update these forward-looking statements.

About HP

HP Inc. creates technology that makes life better for everyone, everywhere. Through our portfolio of printers, PCs, mobile devices, solutions, and services, we engineer experiences that amaze. More information about HP Inc. is available at